Gara Jalqabaatti › Burkitt Lymphoma › California › Orange
Qorannoo klinikaalii Burkitt Lymphoma Orange, CA keessatti
Qorannoo 9 Burkitt Lymphoma f Orange fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
- Children's Hospital of Orange County, Orange
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Namoota walitti qabaa jiraSadarkaa 2
- Children's Hospital of Orange County, Orange
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
- UC Irvine, Orange
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
- Children's Hospital of Orange County, Orange
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Namoota walitti qabaa jiraSadarkaa 3
- Children's Hospital of Orange County, Orange
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Namoota walitti qabaa jiraSadarkaa 2
- Children's Hospital Orange County, Orange
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Namoota walitti qabaa jiraSadarkaa 1/2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Qorannoo Burkitt Lymphoma magaalota biroo keessatti
- Houston, TXQorannoo 21
- Milwaukee, WIQorannoo 16
- Philadelphia, PAQorannoo 16
- New York City, NYQorannoo 14
- Chicago, ILQorannoo 14
- Cincinnati, OHQorannoo 12
- Atlanta, GAQorannoo 12
- Seattle, WAQorannoo 11
- Boston, MAQorannoo 10
- Durham, NCQorannoo 10
- Los Angeles, CAQorannoo 10
- Kansas City, MOQorannoo 10
Qorannoo biroo Orange keessatti
- Kansara Qara'a Non-Small CellQorannoo 25
- Kansara MetastatikiiQorannoo 20
- Kansarii ColorectalQorannoo 16
- Kansarii OvariiQorannoo 16
- Kansarii PancreasQorannoo 15
- Saree OljooQorannoo 14
- Dhibee QaraQorannoo 14
- Kansarii ProstateQorannoo 14
- Dhibee Harkaa (Hepatocellular Carcinoma)Qorannoo 14
- MelanomaQorannoo 14
- Leukemia Myeloidii HamaaQorannoo 13
- Saree (Gosoota Hunda)Qorannoo 13
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.